| |
Univariate
|
Multivariate
|
|---|
|
Odds ratio
|
95% CI
|
P value
|
Odds ratio
|
95% CI
|
P value
|
|---|
|
Age ≥ 70 years
|
1.125
|
0.334–3.787
|
1.000
| | | |
|
Male
|
1.414
|
0.359–5.669
|
0.849
| | | |
|
ASA score 2 or 3
|
2.055
|
0.425–9.942
|
0.362
| | | |
|
PNI < 45
|
1.040
|
0.261–4.143
|
0.956
| | | |
|
mGPS 1 or 2
|
2.361
|
0.641–8.694
|
0.186
| | | |
|
BMI < 22 kg/m2
|
0.472
|
0.140–1.590
|
0.218
| | | |
|
Bilobed tumour
|
1.552
|
0.439–5.480
|
0.492
| | | |
|
Tumour size ≥ 30 mm
|
3.717
|
0.951–14.53
|
0.046
|
2.633
|
0.425–7.359
|
0.203
|
|
Number of tumours ≥ 4
|
0.327
|
0.084–1.277
|
0.094
| | | |
|
Metachronous occurrence
|
0.757
|
0.226–2.541
|
0.652
| | | |
|
CEA ≥ 10 ng/dl
|
1.512
|
0.456–5.013
|
0.497
| | | |
|
CA19-9 ≥ 20 mU/l
|
1.887
|
0.535–6.658
|
0.318
| | | |
|
Major resection
|
2.697
|
0.797–9.000
|
0.101
| | | |
|
Synchronous resection for primary tumour
|
1.008
|
0.123–9.460
|
0.945
| | | |
|
Operation time ≥ 480 min
|
3.407
|
1.002–11.583
|
0.040
|
1.768
|
0.592–11.703
|
0.433
|
|
Operative blood loss > 600 ml
|
8.205
|
1.708–39.420
|
0.003
|
9.564
|
1.913–47.811
|
0.006
|
|
H group
|
10.377
|
1.292–83.337
|
0.008
|
12.326
|
1.478–102.784
|
0.020
|
|
Low PMI group
|
0.504
|
0.129–1.974
|
0.318
| | | |
- ASA score American Society of Anesthesiologists classification score, BMI body mass index, CA19–9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, CI confidence interval, H group high intramuscular adipose tissue content group, mGPS modified Glasgow prognostic score, PMI psoas muscle index, PNI prognostic nutritional index
